Which adjunctive therapy is indicated for Pneumocystis jirovecii pneumonia when PaO2 is less than 70 mmHg?

• A. Azithromycin
• B. Prednisone taper over 21 days
• C. Dexamethasone taper over 14 days
• D. Ciprofloxacin

Answer: (B)

When Pneumocystis jirovecii pneumonia causes significant hypoxemia, adding a corticosteroid to the antibiotic treatment helps blunt the inflammatory response in the lungs as the organisms are killed, which lowers mortality and improves oxygenation. The threshold of PaO2 below 70 mmHg marks severe disease where this adjunctive therapy is beneficial.

The best choice is a prednisone taper over 21 days: start high-dose prednisone (for example, 40 mg twice daily) for about 5 days, then 40 mg daily for the next 5 days, and finally 20 mg daily for the last 11 days. This regimen provides a rapid anti-inflammatory effect early, then a gradual taper to minimize withdrawal and side effects, matching standard guidelines for HIV-related PJP.

Azithromycin and ciprofloxacin do not treat Pneumocystis effectively, and while dexamethasone can be used in some scenarios, the classic tested approach for significant hypoxemia is prednisone with the 21-day taper.